[Overweight, obesity and chronic mal nutrition in 6 to 9 year-old children in Peru, 2009-2010]

Insights

Chronic malnutrition (CM) is decreasing in Peruvian children, but obesity has doubled. This dual burden of malnutrition and obesity presents significant challenges for public health nutrition policies in Peru.

Area of Science:

  • Pediatric Nutrition
  • Public Health
  • Epidemiology

Context:

  • Childhood overweight and obesity are growing global concerns.
  • Understanding nutritional status in diverse populations is crucial for targeted interventions.
  • Peru faces a complex nutritional landscape with coexisting malnutrition and obesity.

Purpose:

  • To determine the prevalence of overweight, obesity, and chronic malnutrition in 6- to 9-year-old children in Peru.
  • To analyze regional variations in these nutritional indicators.
  • To inform public health and nutrition policy development.

Summary:

  • A cross-sectional study using 2009-2010 National Household Survey data analyzed 6- to 9-year-old children in Peru.
  • Prevalence rates for overweight and obesity varied by reference (Must vs. WHO), with CM rates at 15.4% (NCSH) and 17.8% (WHO).
  • Chronic malnutrition was highest in the Highlands, while obesity was more prevalent on the coast and in Lima. Co-occurrence of CM with overweight/obesity was noted.

Impact:

  • While chronic malnutrition shows signs of decrease, the doubling of obesity rates highlights a critical public health issue.
  • The co-existence of undernutrition and overnutrition necessitates integrated food and nutrition policies.
  • Findings underscore the need for region-specific strategies to address Peru's evolving nutritional challenges.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
2.0K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324